Grégory Ehx

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 24, 2025
Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma.

Mégane Jassin, Chloé Onkelinx, Valentina Bocuzzi

|May 22, 2025
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.

Anca Apavaloaei, Qingchuan Zhao, Leslie Hesnard

|Apr 16, 2024
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia.

Nandita Noronha, Chantal Durette, Maxime Cahuzac

|Aug 15, 2023
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.

Maria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jean-David Larouche

|Mar 05, 2021
High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Caroline Ritacco, Grégory Ehx, Céline Grégoire

|Jan 29, 2021
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis.

Grégory Ehx, Caroline Ritacco, Muriel Hannon

Pageof 2

Frequent Collaborators

3 joint publications

Claude Perreault

2 joint publications

Nandita Noronha

2 joint publications

Maxime Cahuzac

2 joint publications

Jean-Philippe Laverdure